Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Owens & Minor ( (OMI) ) has provided an update.
On December 31, 2025, Owens & Minor completed the sale of its Products & Healthcare Services business, including the Owens & Minor brand, to Platinum Equity for $375 million in cash, subject to customary adjustments, and retained a 5% equity stake, thereby finalizing its transformation into Accendra Health, a pure-play home-based care company. In connection with the closing, the company put in place an amended and restated receivables sale program of up to $150 million that will be accounted for as true sales under ASC 860, adjusted its capital structure via releases under certain credit facilities and indentures, exited its P&HS executive leadership roles while consolidating accounting responsibilities under CFO Jonathan Leon, amended its executive deferred compensation plan for departing P&HS participants, and filed corporate amendments to change its legal name to Accendra Health, Inc., with NYSE trading under the new name and ticker “ACH” expected to begin on January 2, 2026.
The most recent analyst rating on (OMI) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on Owens & Minor stock, see the OMI Stock Forecast page.
Spark’s Take on OMI Stock
According to Spark, TipRanks’ AI Analyst, OMI is a Neutral.
Owens & Minor’s overall stock score is primarily impacted by its poor financial performance, with significant challenges in revenue, profitability, and cash flow. The technical analysis indicates a bearish trend, and the valuation is unattractive due to negative earnings and no dividend yield. The earnings call provided some positive strategic shifts, but these are overshadowed by ongoing operational issues and financial instability.
To see Spark’s full report on OMI stock, click here.
More about Owens & Minor
Owens & Minor, Inc., which will be renamed Accendra Health, Inc., is repositioning itself as a nationwide pure-play home-based care platform focused on supporting patients with chronic conditions through its Apria and Byram brands. Following the divestiture of its Products & Healthcare Services (P&HS) segment and the Owens & Minor brand, the company’s business centers on a comprehensive home-care product portfolio, broad payor contracts and a national footprint aimed at driving durable growth in the home-based care market.
Average Trading Volume: 1,958,623
Technical Sentiment Signal: Sell
Current Market Cap: $213.5M
For an in-depth examination of OMI stock, go to TipRanks’ Overview page.